Clinical monitoring

Global Medical Device Contract Research Organization (CRO) Market Analysis Report 2021 by Phase (Preclinical, Clinical), & Service (Regulatory/Medical Affairs, Clinical Monitoring) - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 6, 2022

The "Medical Device Contract Research Organization Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), by Service (Regulatory/Medical Affairs, Clinical Monitoring), by Region (APAC, North America), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Device Contract Research Organization Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), by Service (Regulatory/Medical Affairs, Clinical Monitoring), by Region (APAC, North America), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The main driver of the market includes time-saving, cost efficiency, and expertise in the area, which accelerates the process of devices reaching the market.
  • The presence of well-established players, mid-size firms, and a number of new start-ups offering great opportunities are also contributing to the medical device CRO market growth.
  • Medical Device CRO Market Variables, Trends & Scope

Reven Strengthens Its Clinical Team With Three New Members

Retrieved on: 
Monday, October 5, 2020

Renae Townsend has assumed the role of Director of Clinical Operations and Jenny Daniels has assumed the role of Director of Clinical Quality Assurance.

Key Points: 
  • Renae Townsend has assumed the role of Director of Clinical Operations and Jenny Daniels has assumed the role of Director of Clinical Quality Assurance.
  • Both Renae and Jenny have 15+ years of Good Clinical Practice (GCP), clinical research and clinical monitoring experience.
  • These new team members will help us provide sponsor oversight for the services rendered by the clinical research organizations (CRO) and other vendors who will support our clinical RJX program and execution of the clinical trial.
  • Our new team members each will have a very important role in our efforts aimed at evaluating the clinical impact potential of RJX, added Peter Lange, CEO of Reven.

ClinOne to Launch Breakthrough Continuous Patient COVID-19 Monitoring Solution Through Wearables Partnership with BioIntelliSense

Retrieved on: 
Tuesday, May 12, 2020

ClinOne is expanding its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne ClinTrialConnect patient portal platform.

Key Points: 
  • ClinOne is expanding its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne ClinTrialConnect patient portal platform.
  • Our combined capabilities position ClinOne and BioIntelliSense to become the gold standard across all interventional clinical trials, according to Rob Bohacs.
  • The ClinOne solution and its suite of products were created to improve clinical trial enrollment, retention, virtual patient management and remote clinical monitoring.
  • BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).